---
created: 2025-04-13
updated: 2025-04-13T10:53
id: HP:J+-<g/`
specialty: pharmaco
specialty_id: 534
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::13-infectious-disease::06-viruses::08-antiviral-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies::ribavirin
  - "source/ak-step1-v11:": 
  - theme/firstaid::03-microbiology::07-antimicrobials::54-hepatitis-c-therapy
  - "source/ak-step1-v11:": 
  - theme/firstaid::03-microbiology::07-antimicrobials::56-antimicrobials-to-avoid-in-pregnancy
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::08-microbiology::28-antivirals
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::02-antivirals::10-hepatitis-c-therapy
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::07-antimicrobials::08-antivirals-hepatitis::ribavirin,sofosbuvir,simeprevir
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^fa-updates::fa2018
  - source/ak-step1-v11::^other::^highyield::3-highyield-temporary"
type: flashcard
---

# Question
Ribavirin is extremely contraindicated in what patient population?   **Pregnant patients**

---

# Answer
- Ribavirin is a severe teratogen and embryocidal agent - do not use in individuals of childhood bearing capability - women AND men